Jesús Prìeto

Hebron University — PS

Medicine · Health Sciences

91h-index31.2kcitations965works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(161), Virus-based gene therapy research(146), Hepatitis C virus research(107), Immunotherapy and Immune Responses(77), Liver Disease and Transplantation(70)

Publications965 total

Principales novedades de la ley de medidas en materia de eficiencia del servicio público de justicia que afectan a la jurisdicción contencioso-administrativa
2025
MEF2D-expressing cancer precursors reprogram tissue-resident macrophages to support liver tumorigenesis
Nature Cancer·2025
Screening for Mutations Causing ACOX2 Deficiency-associated Hypertransaminasemia in Patients with Cryptogenic Liver Injury
Journal of Clinical and Translational Hepatology·2025Open Access
Pumping up your predictive power for cognitive state detection with the proper GAINS
NeuroImage·2025· 2 citedOpen Access
105P Immune-related adverse events (irAE) and pathological complete response (pCR) in early TNBC (eTNBC) treated with pembrolizumab (P) plus chemotherapy (CT)
ESMO Open·2025Open Access
Pumping Up your Predictive Power for Cognitive State Detection with the Proper GAINS
2025
Democracia, política y administración inteligentes en tiempos críticos
2025
Reflexiones acerca de la Ley de eficiencia (LO 1/2025)
2025
Nuevos desafíos de la educación superior: transformando la docencia universitaria
2025
Mediation, ODR, and the web 2.0: a case for relational justice
Figshare·2024· 2 citedOpen Access
Linda index forecast based on ARIMA time series
Journal of Infrastructure Policy and Development·2024Open Access
Supplemental Figure Legends from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
2023Open Access
Supplementary Figure S3 from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
2023Open Access
Supplementary Figure S4 from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
2023Open Access
Supplementary Methods and References from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
2023Open Access
Supplementary Figure S3 from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
2023Open Access
Supplementary Tables S1-S4 from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
2023Open Access
Supplementary Figure S1 from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
2023Open Access
Supplementary Tables S1-S4 from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
2023Open Access
Data from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
2023Open Access
page 1 of 49Next →

Frequent Co-authors

Bruno Sangro(16), Jorge Quiroga(11), Carmen Berasain(10), Ignacio Melero(9), Matías A. Ávila(9), Cheng Qian(7), Juan José Lasarte(6), Alberto Benito(6), Josefa Castillo(5), Guillermo Mazzolini(5), Mercedes Iñarrairaegui(4), Pablo Sarobe(4), María U. Latasa(4), Juan Ruiz(4), Ignacio Herrero(4), Francisco J. Blanco(4), Guillermo Montoya(4), Frédéric Pâques(4), Philippe Duchâteau(4), J.I. Herrero(4)